Seung-il Shin

Biography

 Seung-il Shin joined the board of GSID in August 2008. Dr. Shin began his career as a Professor of Genetics at Albert Einstein College of Medicine in New York, and as a founding member of the Basel Institute of Immunology in Switzerland. In 1984, Dr. Shin co-founded and served as the Chief Executive Officer of Eugene Tech International, where he led the company's effort to develop and market a hepatitis B vaccine that was eventually distributed widely in many developing countries. While working as a Senior Health Advisor for the United Nations Development Programme, Dr. Shin conceived, founded, and directed the initiative to establish the International Vaccine Institute in Seoul, South Korea, devoted to the promotion of vaccine sciences for developing countries. Beginning in 1999, Dr. Shin became the Senior Advisor for International Development for VaxGen. Together with Don Francis and Carter Lee, Dr. Shin initiated the development of Celltrion, a US-South Korean joint venture to provide manufacturing capacity to ensure adequate global supply of AIDVAX vaccine. Until 2009, Dr. Shin served as the Chairman of the Scientific Advisory Board and oversaw business development for Celltrion.

Research Interest

 Research on Immunological Studies